Emyria LtdASX: EMD

Emyria adds wearables to psychedelic-assisted therapy trials

· Issued by Emyria Ltd

Filed with ASX · · 5 pages · English

● Emyria has signed a letter of intent (LOI) with Cydelic - a private company based in Seattle developing tools and technologies that help track the wellbeing of patients before, during and after psychedelic-assisted therapy ● Emyria plans to work with Cydelic across all of its psychedelic-assisted therapy programs to capture unique biometric data that can assist with real-time patient safety and

Emyria Ltd on 6ix

Earlier from Emyria

Later from Emyria

All Emyria news releases